Replies to post #113423 on Avid Bioservices Inc (CDMO)

[chenzo11]

I couldn't agree more. Well said

[horselover45]

First let me congratulate your birth ahead of time .

Tom is your 6 mo anniversary.

Second where the pancreatic trial was missed I do believe that MOJO nailed the second line lung cancer trial and I will bet that he will be damn close with the frontline lung trial.

Not to sound redundant but even you should know that with this platform you don't just decide to do a deal.You get one shot and you better do it right.

Have a nice sunday,
Andy C.

[soulofwolf]

Well said!

[pphmtoolong]

I have had my login for years. Funny how similar yours is to mine. Be that as it may. Stripped of the hostile tone the content of your message actually has some merit. It has merit in the sense that Peregrine has reached the point where partnering of Cotara and Bavi is necessary. I don't think anyone, either in Peregrine management or among us shareholders, disagrees with that. We will soon see how valuable Cotara and Bavi are. As others have noted though, waiting a little longer for the FDA assessment of the clinical trials, i.e. Bavi Phase III go ahead, may be enough to prompt a deal. It may even be lucrative enough to justify a very long wait.

Keep smiling,

Paul

[biopharm]

Independent verification, that is the only thing that will move this stock forward. I have said it many times and it should be clear to anyone since the last two press releases did nothing.
Stop talking about "we are in talks", just sign a licensing deal and be done with it. The longer this goes on without a deal, the more obvious it is that what we have here may not be worth much.
Also, I think it is time to stop trying to predict how well a trial is going based on the fact that we have not heard results yet. How well did that work with the pancreatic trial? One word, terribly. For years we have been told, potential partners want to see interim phase II results, then more complete phase II results.
Well,we have that. They are running out of excuses. Then they will run out of money or be forced to finance to the detriment of current shareholders which we are used to.

PPHMVERYLONG, didn't you see the results in February of 2016 for that independent verification ? Oops, it is not Feb 2016 yet, lets revisit that at the end of the Feb, which begins tomorrow : )

As for making deals, Peregrine has made some superb ones and the public ones were with MSK, AZ and NCCN. Maybe some other non-public deals are awaiting certain events to happen ?

I do find it interesting at the arrival time of August 2012 and so much concentration put back on the pancreatic trial....hmmmm, who knows, maybe CSM in Fargo ND had some part of that as well

As for "they will run out of money.." Nope, they will not run out of money but will build a fortune in PS Targeting, licensing revenues IMO : )